Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Juno Therapeutics Cmn (NASDAQ: JUNO)


Last Updated: Dec-07-2016 20:14:03

Premium Research

Juno Therapeutics Cmn (NASDAQ: JUNO) Profile

Volume2,458,700
Open$19.63
Prior Close$19.6
Market Cap$2 B
PE Ratio
Beta2.25
Juno Therapeutics Inc. is a biopharmaceutical company. The Company develops cellular immunotherapies based on two platforms - Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Its clinical CD19 product candidates include JCAR015 that is in Phase I clinical trials for adult patients with relapsed/refractory B cell acute lymphoblastic leukemia (r/r ALL); JCAR017 which is in Phase I/II trials for pediatric patients with r/r ALL whose cancer has recurred after a bone marrow transplant; and JCAR014 that is in Phase I/II trials to treat various B cell malignancies in patients relapsed or refractory to standard therapies. Juno Therapeutics Inc. is headquartered in Seattle Washington.
SymbolCompanyMarket cap
AMGNAmgen$107.95 B
GILDGilead Sciences Inc$95.48 B
CELGCelgene Corp$91 B
BIIBBiogen Inc Cmn$63.35 B
REGNRegeneron Pharmaceutical$38.91 B
BXLTBaxalta Incorporated Common Sto$31.46 B
ALXNAlexion Pharm Inc$27.84 B
INCYIncyte Corporation$20.2 B
VRTXVertex Pharmaceutic$19.38 B
ILMNIllumina Inc$18.57 B

JUNO Earnings

1st Quarter Earnings$-0.57 (2016-11-09)
2nd Quarter Earnings$-0.64 (2016-08-04)
3rd Quarter Earnings$-0.78 (2016-05-09)
4th Quarter Earnings$-0.53 (2016-02-29)
PE Ratio0
EPS Growth-43.2%
Recent Earnings$-0.57
Annual EPS$-2.56
Market Capitalization$2 B
Insider Shareholder %0.1526%
Annual Revenue$0.06 B
Number of Shares Outstanding105,780 Shares
Institutional Shareholder %61.76%
Annual Net Income$-0.28B
TTM Net Profit Margin$-445.83
One Year Return-59.43%
Three Year Return-34.36%
Five Year Return-45.86%
Five Year Revenue Growth0%
Five Year Earnings Growth0%
Five Year Dividend Growth0%
Last Quarter EPS$-0.58
Annual EPS$-2.56
Annual Dividend$0
Annual Dividend Yield0%
Change in EPS YTD-43.200001%
PE Ratio
Recent Earnings$-0.57
Dividends per Share$
Stock Split Ratio
beta2.25

JUNO Key Stats

Last Price$18.95
Net Change$-0.65 (-3.32%)
Bid$18
Ask Price$0
Open Price$19.63
Previous Close Price$19.6
High Price$19.73
Low Price$18.9
Number of Trades9,893
Volume2,458,700
Fifty Two Week High$50.95 (2015-12-08)
Fifty Two Week Low$18.72 (2016-12-06)
Average Daily Volume1,747,176
Share Outstanding105,780 Shares
Total Dividend Payout$0/yr
Dividend Yield0%